1. Antibiotics stimulates the development of persistent cells in biofilms of Candida albicans bloodstream isolates.
- Author
-
Portela FVM, Andrade ARC, Pereira LMG, da Silva BN, Peixoto PHS, Amando BR, Fiallos NM, Souza PFSM, Lima-Neto RG, Guedes GMM, Castelo-Branco DSCM, and Cordeiro RA
- Subjects
- Humans, Antifungal Agents pharmacology, Microbial Sensitivity Tests, Ciprofloxacin pharmacology, Gentamicins pharmacology, Amoxicillin pharmacology, Vancomycin pharmacology, Amikacin pharmacology, Cefepime pharmacology, Amphotericin B pharmacology, Cephalosporins pharmacology, Candidiasis microbiology, Candidiasis drug therapy, Biofilms drug effects, Biofilms growth & development, Candida albicans drug effects, Candida albicans physiology, Anti-Bacterial Agents pharmacology
- Abstract
Candida albicans invasive candidiasis is considered a global health problem. In such cases, biofilm formation on implanted devices represents a therapeutic challenge and the presence of metabolically inactive persistent cells (PCs) in these communities increases their tolerance to fungicidal drugs. This study investigated the influence of amoxicillin, AMX; cefepime, CEF; gentamicin, GEN; amikacin, AMK; vancomycin, VAN; and ciprofloxacin, CIP; on the production of PCs in biofilms of C. albicans bloodstream isolates. 48 h-mature biofilms ( n = 6) grown in RPMI-1640 supplemented with antibiotics were treated with 100 μg ml
-1 amphotericin B and then evaluated for PCs. Biofilms grown in the presence of antibiotics produced more PCs, up to 10×, when exposed to AMX and CIP; 5 × to CEF; and 6 × to GEN and VAN. The results indicate that antibiotics can modulate PC production in C. albicans biofilms. This scenario may have clinical repercussions in immunocompromised patients under broad-spectrum antibiotic therapy.- Published
- 2024
- Full Text
- View/download PDF